Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $662.98 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $164.90 | 3 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $119.30 | 2 | $0 (2018) |
| Amgen Inc. | $118.73 | 1 | $0 (2018) |
| Jazz Pharmaceuticals Inc. | $112.13 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $72.45 | 3 | $0 (2018) |
| Allergan Inc. | $39.76 | 2 | $0 (2019) |
| PFIZER INC. | $20.07 | 1 | $0 (2024) |
| Medtronic Vascular, Inc. | $15.64 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.07 | 1 | PFIZER INC. ($20.07) |
| 2019 | $16.20 | 1 | Allergan Inc. ($16.20) |
| 2018 | $441.84 | 8 | Novartis Pharmaceuticals Corporation ($119.30) |
| 2017 | $184.87 | 4 | Alexion Pharmaceuticals, Inc. ($104.22) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/07/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/27/2018 | Jazz Pharmaceuticals Inc. | Defitelio (Drug) | Food and Beverage | In-kind items and services | $112.13 | General |
| Category: Hematology | ||||||
| 06/21/2018 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: Immunology | ||||||
| 06/11/2018 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug) | Food and Beverage | In-kind items and services | $94.75 | General |
| Category: ONCOLOGY | ||||||
| 05/17/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/14/2018 | Amgen Inc. | Vectibix (Biological) | Food and Beverage | In-kind items and services | $118.73 | General |
| Category: Oncology | ||||||
| 02/13/2018 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $35.03 | General |
| Category: Immunology | ||||||
| 02/06/2018 | Medtronic Vascular, Inc. | Reveal LINQ (Device) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 11/07/2017 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $104.22 | General |
| Category: Immunology | ||||||
| 11/03/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $33.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/29/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/08/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 298 | 608 | $229,562 | $59,611 |
| 2022 | 6 | 281 | 725 | $239,577 | $57,027 |
| 2021 | 6 | 279 | 657 | $194,339 | $46,985 |
| 2020 | 5 | 290 | 693 | $173,038 | $43,658 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 96 | 274 | $108,778 | $30,402 | 27.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 92 | 221 | $60,996 | $16,041 | 26.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 40 | 41 | $31,816 | $6,155 | 19.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 25 | 27 | $11,043 | $2,846 | 25.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 28 | 28 | $7,868 | $2,086 | 26.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $9,061 | $2,081 | 23.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 122 | 414 | $114,265 | $27,692 | 24.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 74 | 226 | $89,722 | $21,447 | 23.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 40 | 40 | $11,236 | $2,728 | 24.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $9,245 | $1,887 | 20.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 20 | 20 | $8,180 | $1,844 | 22.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $6,929 | $1,429 | 20.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 143 | 497 | $137,173 | $33,361 | 24.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 28 | 46 | $18,262 | $4,460 | 24.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 27 | 27 | $14,391 | $3,318 | 23.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 41 | 42 | $11,802 | $2,790 | 23.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 23 | 23 | $9,389 | $2,302 | 24.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 17 | 22 | $3,322 | $753.06 | 22.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 123 | 391 | $104,317 | $26,337 | 25.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 61 | 176 | $25,463 | $6,392 | 25.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 68 | 71 | $19,097 | $4,864 | 25.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 23 | 24 | $12,330 | $3,131 | 25.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 15 | 31 | $11,831 | $2,933 | 24.8% |
About Dr. Ronald Cho, MD
Dr. Ronald Cho, MD is a Internal Medicine healthcare provider based in Valhalla, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457388977.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Cho, MD has received a total of $662.98 in payments from pharmaceutical and medical device companies, with $20.07 received in 2024. These payments were reported across 14 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($662.98).
As a Medicare-enrolled provider, Cho has provided services to 1,148 Medicare beneficiaries, totaling 2,683 services with total Medicare billing of $207,280. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Valhalla, NY
- Active Since 06/28/2006
- Last Updated 10/04/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1457388977
Products in Payments
- SOLIRIS (Drug) $164.90
- Vectibix (Biological) $118.73
- Defitelio (Drug) $112.13
- AFINITOR (Drug) $94.75
- XARELTO (Drug) $57.09
- ENTRESTO (Drug) $24.55
- LINZESS (Drug) $23.56
- ELIQUIS (Drug) $20.07
- VRAYLAR (Drug) $16.20
- Reveal LINQ (Device) $15.64
- INVOKANA (Drug) $15.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Valhalla
Dr. Jay Doshi, M.d, M.D
Internal Medicine — Payments: $96,684
Luciano De Marco, M.d, M.D
Internal Medicine — Payments: $14,149
Neal Shah, M.d, M.D
Internal Medicine — Payments: $5,403
Sade Solola Nussbaum, Md, MD
Internal Medicine — Payments: $4,024
Rhonda Rubin, Md, MD
Internal Medicine — Payments: $2,982
Adrese Kandahari, M.d, M.D
Internal Medicine — Payments: $2,880